Novavax is a biotech company with a proven technology, focused on developing our R&D assets and establishing partnerships to help protect health.

May 20, 2025 · The Novavax vaccine is one of three vaccines available in the U.S. for the prevention of COVID-19 and the only one that does not use the relatively new mRNA vaccine …

The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic …

On August 27, 2025, the Food and Drug Administration revoked the Emergency Use Authorization (EUA) for Novavax COVID-19 Vaccine, Adjuvanted. Nuvaxovid (COVID-19 Vaccine, Adjuvanted), …

May 18, 2025 · May 19, 2025 – The FDA has approved the Novavax COVID-19 vaccine, a protein-based alternative to mRNA shots, with some limits on who can get it.

Find the latest Novavax, Inc. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Navigate global information about the authorization or approval status of the Novavax COVID-19 Vaccines worldwide.

Oct 7, 2024 · Novavax vaccine finder provides the most timely and updated information on the locations where our vaccine is available this season.

Sep 10, 2024 · Novavax is a protein subunit vaccine and is based on a more traditional vaccination approach than mRNA vaccines. It contains a lab-made version of the SARS-CoV-2 spike protein …

Oct 7, 2025 · The 2025-2026 Novavax COVID-19 vaccine, called Nuvaxovid, is FDA approved and recommended for adults and adolescents ages 12 and older. You can look for the Nuvaxovid vaccine …